| Project Detail |
Location:
Greece
Project number:
55619
Business sector:
Manufacturing and Services
Notice type:
Private
Environmental category:
B
Approval date:
26 Jul 2024
Status:
Disbursing
English-language PSD published:
21 Oct 2024
Equity co-investment of up to EUR 25 million, alongside Mid Europa, for the acquisition of Famar (the "Company" or the "Target"), a European pharmaceutical Contract Development and Manufacturing Organisation ("CDMO").
Project Objectives
The Banks equity investment alongside Mid Europa will enable the transformation of Famar towards higher-value-added products with an enhanced set of R&D capabilities, and a potential for the Company to become a platform for further acquisitions in the Central and South Eastern Europe region. |
